Late acute thrombosis after paclitaxel eluting stent implantation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11514475.
- Also identified by PMC identifier 1729898.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Late (more than six months) total occlusion after coronary stenting is a progressive phenomenon occurring in approximately 4% of patients, leading to acute myocardial infarction in less than 0.5%. The process must be related to severe and progressive intimal hyperplasia. In patients receiving coronary stenting with simultaneous brachytherapy, late total occlusion has been reported at a higher rate and to be related to stent thrombosis rather than intimal hyperplasia. Late total occlusion presenting with an acute clinical event seven months after the implantation of a paclitaxel drug eluting stent is reported. The occlusion developed soon after the interruption of ticlopidine treatment, suggesting that the event had a thrombotic genesis and that the risk is not confined to the first six month period.
Medical subject headings
- Angiogenesis Inhibitors
- Coronary Disease
- Myocardial Infarction
- Paclitaxel
- Stents